York Capital Management Global Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-120,004	Closed	-$3.35M	–	69
2017 Q2	$3.35M	Buy	+120,004	New	+$3.35M	0.07%	64